Metagenomi, Inc Common Stock

Yahoo Finance • 17 days ago

After-Hours Gainers: Exicure Tops List With 72% Jump, Wave Life And Assembly Biosciences Advance

(RTTNews) - Biotechnology stocks saw notable movement in after-hours trading on Monday, with several companies posting strong gains. Below is a structured look at the key movers and the developments driving their performance. Exicure, Inc... Full story

Yahoo Finance • 24 days ago

Trainium3 UltraServers Now Available: Enabling Customers to Train and Deploy AI Models Faster at Lower Cost

Amazon EC2 Trn3 UltraServers powered by AWS's first 3nm AI chip help organizations of all sizes run their most ambitious AI training and inference workloads LAS VEGAS, December 02, 2025--(BUSINESS WIRE)--At AWS re:Invent, Amazon Web Servi... Full story

Yahoo Finance • 24 days ago

Amazon Launches New AI Chip While Teasing Future Tech Collaboration With Nvidia

Amazon stock was higher after the tech giant announced its Trainium3 AI chip is now available for customers of AWS. Continue Reading... Full story

Yahoo Finance • 25 days ago

Biotech Momentum Builds In After-Hours Trading As BioAtla, Entero, And Sonnet Climb

(RTTNews) - Several small-cap biotech and healthcare stocks posted notable gains in after-hours trading on Friday, November 28, 2025, despite limited fresh news flow. Below is a roundup of the key movers. BioAtla Inc. (BCAB) shares surged... Full story

Yahoo Finance • 2 months ago

Metagenomi to use Amazon's chips for gene-editing tools

[Abstract luminous DNA molecule. Genetic and gene manipulation concept. Cut of replacing part of a DNA molecule. Medicine. Innovative in science. Medical science and biotechnology.] ipopba/iStock via Getty Images Biotech company Metagenom... Full story

Yahoo Finance • 2 months ago

Metagenomi taps Amazon's custom chips to develop gene-editing tools

By Stephen Nellis SAN FRANCISCO (Reuters) -Biotech firm Metagenomi said it is using artificial intelligence chips from Amazon.com's cloud computing unit to power some of its work in developing gene-editing technologies. The work represen... Full story

Yahoo Finance • 2 months ago

AI Infrastructure Partnership (AIP), MGX, and BlackRock’s Global Infrastructure Partners (GIP) to Acquire All Equity in Aligned Data Centers

Aligned Data Centers Is an Industry-Leading Provider of Innovative, Sustainable, and Adaptive Digital Infrastructure Powering the World’s Most Complex and Demanding Cloud and AI Workloads NEW YORK & ABU DHABI, United Arab Emirates & DALLA... Full story

Yahoo Finance • 3 months ago

OpenAI now worth $500 billion, possibly making it the world's most valuable startup

OpenAI could now be the world's most valuable startup, ahead of Elon Musk's SpaceX and TikTok's parent company ByteDance, after a secondary stock sale designed to retain employees at the ChatGPT maker. Current and former OpenAI employees... Full story

Yahoo Finance • 3 months ago

OpenAI is the world’s most valuable private company after private stock sale

Image Credits:Thomas Fuller / SOPA Images / LightRocket / Getty Images OpenAI has sold $6.6 billion in shares held by current and former employees, according to a new report from Bloomberg. The sale pushed OpenAI’s total valuation to $500... Full story

Yahoo Finance • 3 months ago

MGX joins Silver Lake as co-investor in semiconductor company Altera

MGX, a United Arab Emirates-based investor in AI and advanced technologies, has joined Silver Lake as a co-investor in acquiring a 51% stake in Altera. Based in California, US, Altera specialises in programmable semiconductor solutions.... Full story

Yahoo Finance • 4 months ago

Databricks projects $4 billion in annual revenue on surging AI demand

(Reuters) -Analytics firm Databricks (DATB.PVT) was on track to hit $4 billion in annual revenue, up more than 50% from the prior year, on the back of surging demand for its AI products. In the second quarter, the company serving around 1... Full story

Yahoo Finance • 4 months ago

Earnings call transcript: Mount Gibson Iron Q4 2025 highlights strategic shift

Mount Gibson Iron Ltd (MGX) reported its Q4 2025 earnings, showcasing a strategic pivot towards diversification and growth despite the absence of earnings forecasts. The company’s shares rose by 5.33% following the earnings call, closing a... Full story

Yahoo Finance • 4 months ago

Metagenomi Inc (NASDAQ:MGX) Q2 2025 Earnings: Revenue Surpasses Estimates, Loss Narrower Than Expected

METAGENOMI INC (NASDAQ:MGX [https://www.chartmill.com/stock/quote/MGX]) REPORTS Q2 2025 EARNINGS: REVENUE BEATS ESTIMATES, LOSS NARROWS Metagenomi Inc, a precision genetic medicines company, reported its second-quarter 2025 financial resu... Full story

Yahoo Finance • 5 months ago

Metagenomi Showcases Advanced AI-Enhanced Gene Editing for Neurological Disorders at ASGCT Meeting

Metagenomi Inc. (NASDAQ:MGX) is one of the best young stocks to buy and hold for 5 years. In mid-May, Metagenomi announced the presentation of 3 abstracts at the American Society of Gene & Cell Therapy/ASGCT 28th Annual Meeting, which was... Full story

Yahoo Finance • 6 months ago

3 Penny Stocks With Market Caps Over $80M To Watch Closely

The U.S. stock market has been navigating a wave of uncertainty, with recent tariff threats from President Trump causing fluctuations across major indices such as the Dow Jones, S&P 500, and Nasdaq. Amid these broader market dynamics, penn... Full story

Yahoo Finance • 7 months ago

Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025

- Potential best-in-class extrahepatic in vivo gene editing with all-in-one delivery to the central nervous system (CNS) is a critical milestone for the treatment of neurological disorders - - Advancements demonstrate the ability to speci... Full story

Yahoo Finance • 7 months ago

Metagenomi Reports Business Updates and First Quarter 2025 Financial Results

- Nonhuman primate (NHP) study in hemophilia A demonstrated therapeutically relevant factor VIII (FVIII) activity with durable response through approximately 19 months with an encouraging safety profile - Well capitalized with $226.0 mill... Full story

Yahoo Finance • 9 months ago

Metagenomi Reports Business Updates and Full Year 2024 Financial Results

Hemophilia A presentation at American Society of Hematology (ASH) 66th Annual Meeting demonstrated sustained Factor VIII (FVIII) activity in nonhuman primate (NHP) study for more than 16 months Leveraged hemophilia A albumin platform to a... Full story

Yahoo Finance • 9 months ago

Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems

Achieved targeted integration of a large, therapeutically relevant gene into the genome of human cells with compact CAST system AI-driven metagenomics platform facilitated discovery of CAST system with activity in human cells Expression... Full story

Yahoo Finance • 10 months ago

Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference

EMERYVILLE, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today anno... Full story